AI-PIA · Digital health & life sciences
AI Privacy Impact Assessment for AI Scribe & Clinical AI Vendors
An AI Privacy Impact Assessment is now the entry ticket to an Ontario AI scribe deployment: the IPC's January 2026 guidance effectively tells custodians not to proceed without one, and it names specifics — audio retention necessity, consent handling, secondary use for training — a general-purpose PIA template doesn't cover. The trigger is a hospital or clinic asking for this before a pilot, or a program pre-qualification application that treats it as required evidence. We build the assessment around your actual audio and inference pipeline, not a generic AI checklist.
Reviewed by the Privacy Horizon team · Last reviewed
What you're protecting
What an AI-PIA has to examine for an ambient scribe
A standard PIA asks what personal information a system collects. This assessment has to go further into how a model actually behaves on that information.
Necessity of full audio retention
A direct assessment of whether keeping raw consult audio beyond note generation is actually necessary, since the IPC guidance puts this question at the centre of custodian review.
The lawful basis for any secondary use
Whether recordings or transcripts are ever used to improve the model, and if so, whether that use rests on valid consent or de-identification meeting a very low re-identification risk — a bar the guidance signals audio essentially never meets on its own.
Per-encounter consent and the decline pathway
How consent is captured, what patients are told, and — critically — confirmation that a patient who declines recording receives the same standard of care as one who consents.
Human-in-the-loop review
Where and how a clinician reviews a generated note before it becomes part of the record, and what happens when review is skipped under time pressure.
Bias from excluded patients
Whether non-consenting patients being systematically absent from any training or evaluation data introduces its own fairness distortion, a risk the guidance specifically tells custodians to probe.
The full sub-processor and inference chain
Every point consult audio passes through — ASR provider, LLM inference, vector store, QA review — assessed as its own risk, including cross-border disclosure where inference runs outside Canada.
Regulatory map
What makes this assessment mandatory rather than optional here
Unlike a general AI product, an ambient scribe now has a named regulatory checklist pointing directly at it.
The IPC guidance that makes this assessment mandatory
Ontario's privacy regulator published considerations aimed squarely at this product category, placing PIAs, consent handling, audio retention and human review at the centre of what custodians must address.
Alberta's statutory pre-filing requirement
The Health Information Act requires a custodian to file a Privacy Impact Assessment with the OIPC before implementing a system like a scribe, making this document a legal precondition to launch, not a best practice.
The ESP necessity limit the assessment has to test
Electronic service providers may only use PHI as necessary to deliver the service under O. Reg. 329/04, and the AI-PIA is where you demonstrate, not just assert, that the model's actual training and retention behaviour stays inside that boundary.
The OPC's generative AI principles
Legal authority, necessity and proportionality, traceable and explainable outputs, and developer duties including adversarial testing — the December 2023 principles shape what a thorough assessment has to document.
Norton Rose Fulbright's read on the de-identification bar
Legal analysis of the IPC guidance concludes that raw audio essentially never meets the de-identification threshold required for training use without consent, a conclusion the assessment should treat as the working assumption.
What goes wrong
What the assessment is designed to catch before deployment
These are the specific failure points the IPC's guidance was written in response to.
Secondary use of PHI for model training without valid consent
The central risk the guidance targets — an architecture or contract that permits training on customer PHI without a lawful basis, discovered only when a custodian or auditor asks directly.
Retention sprawl of 'temporary' audio
Recordings kept for quality assurance that never actually expire, turning a defensible short-term practice into an indefensible long-term exposure.
A consent workflow that changes care
A decline pathway that, in practice, results in a different or delayed care experience — the specific outcome the guidance says custodians must avoid.
Sub-processor compromise cascading across custodians
A breach at the ASR or LLM layer exposing PHI across every custodian using that sub-processor simultaneously, a scenario the assessment's risk section should model explicitly.
Our ai-pia for ai scribe & clinical ai vendors
What our AI-PIA service covers for an ambient scribe or clinical AI product
Data-handling review, bias and misuse consideration, regulatory alignment and ethical-use guidance, applied to a product where the guidance names the exact questions to answer.
Data handling review
A detailed evaluation of how audio, transcripts and model outputs move through the product, mapped against the specific retention and use questions the IPC guidance raises.
Bias and misuse consideration
Review of where excluding non-consenting patients from training or evaluation data could distort model performance, alongside standard misuse and fairness questions.
Regulatory alignment overview
A structured comparison of your current practices against the IPC guidance, PHIPA's ESP framework, Alberta's HIA and the OPC's generative AI principles.
Ethical and responsible use guidance
Principles for how the company approaches consent, transparency and human review, written so they can be shown to a custodian rather than kept internal.
A reusable custodian-facing summary
An output version of the assessment a clinic or hospital can incorporate directly into its own PIA, saving both sides from duplicating the analysis.
How the engagement runs
How we run an AI-PIA for a scribe or clinical AI vendor
Structured around the specific questions the IPC guidance raises, not a generic AI-risk template.
Step 1
Map the pipeline and data uses
We trace audio and transcripts from capture through ASR, LLM inference, EMR write-back and any training or evaluation use.
Step 2
Assess necessity and lawful basis
We examine whether current retention and any secondary use are actually necessary, and whether the lawful basis for each use — consent or genuine de-identification — holds up.
Step 3
Evaluate consent, human review and bias
We review the decline pathway, the human-in-the-loop checkpoint, and whether excluded patients introduce a fairness risk in any training or evaluation dataset.
Step 4
Deliver findings and the custodian-facing kit
You receive the full assessment plus a version formatted for custodians to fold into their own PIA process, with a prioritized remediation plan for any gaps found.
What it costs
What determines AI-PIA cost for a scribe or clinical AI vendor
Cost tracks how many distinct data uses are in scope — note generation alone versus note generation plus model training or evaluation — plus how many EMR integrations, sub-processors and provinces' requirements the assessment has to satisfy. A vendor with a training-data program needs a deeper assessment than one that discards audio immediately after note generation.
This work is often the first engagement for a vendor entering Infoway or Ontario Health program pre-qualification, and it typically feeds directly into the PIA kit maintained afterward through a Virtual Privacy Office retainer. We scope the assessment and provide a tailored quote after reviewing your pipeline and current data practices.
AI Scribe & Clinical AI Vendors: AI-PIA questions, answered
A standard PIA maps what personal information is collected and where it flows; an AI-PIA for a scribe goes further into how the model actually uses that information — whether recordings train or evaluate the model, whether that use has a valid lawful basis, and what happens when a human reviews or fails to review the model's output before it becomes part of the record. It also has to assess the necessity of retaining raw audio at all, a question a general PIA template rarely asks explicitly.
The assessment examines whether the population that consents to recording differs systematically from the population that doesn't, and whether a model trained or evaluated only on the consenting group performs differently for patients who were never represented. This is a distinct fairness question from typical algorithmic bias review, since the gap is created by the consent process itself rather than by uneven data collection across demographic groups.
It gave Ontario custodians a specific, named checklist to work from — PIAs, contractual limits on vendor use of PHI, a direct question about whether full audio retention is necessary, and an expectation of human review before a note is finalized. Before this guidance, custodians and vendors often worked from general PHIPA principles applied case by case; now there's a published reference point both sides are expected to work against.
One well-built assessment covering your data flows, retention practices and consent design can be adapted for multiple custodians, since the core architecture doesn't change deal to deal. Structure it as a reusable core plus a short, deployment-specific summary for each new custodian.
The assessment can satisfy the substance of what the Health Information Act requires before implementation, but the custodian remains responsible for actually filing it with the OIPC. A complete, accurate AI-PIA from the vendor removes the biggest barrier to that filing happening on time.
Update it whenever the model provider, retention timeline, consent workflow or training-data practice changes, and review it at least annually even without a specific trigger. The IPC guidance is relatively new, so expect further regulatory clarification that may require revisiting the assessment's conclusions.
More for ai scribe & clinical ai vendors
Other services for this niche
- Privacy & security for ai scribe & clinical ai vendors — overview
- Virtual CISO
- Virtual Privacy Officer
- Penetration Testing
- Incident Response Planning
- Privacy & Security Policy Development
- Privacy & Security Training
- Vendor Security Review & Questionnaire Support
- SOC 2 Readiness
- ISO 27001 Readiness
- HIPAA Readiness
About this service
Answers & guides
- When do you need an AI Privacy Impact Assessment (AI-PIA)?
- Can you use AI scribes in healthcare while protecting PHI?
- What's involved in a Privacy Impact Assessment: inputs, timeline, and cost?
- PIA vs TRA: which assessment do you need (or do you need both)?
- Conducting an AI PIA in Healthcare: A Practical Walkthrough
- AI Scribes in Healthcare: Efficiency Without Exposing PHI
What's Protecting Your Business from the Next Threat?
Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.